Article
Effects of omalizumab treatment on gut microbiome in adolescent patients with chronic spontaneous urticaria
2022-04-19
Abstract excerpt
<title>Abstract</title> <p><bold>Background: </bold>Omalizumab is a humanized anti-immunoglobulin (Ig)E monoclonal antibody that is effective for some patients with chronic spontaneous urticaria (CSU) who do not respond to antihistamines. However, the mechanism by which omalizumab improves urticaria remains obscure. Gut microbiome plays a role in the pathogenesis of allergies. Here, we aimed<bold> </bold>to inves...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d200b615-231c-5326-a871-c75b98e502de
- DOI
- 10.21203/rs.3.rs-1561183/v1
